PTEN loss compromises homologous recombination repair in astrocytes: implications for GBM therapy with temozolomide or PARP inhibitors

Por McEllin, Brian, Camacho, Cristel V., Mukherjee, Bipasha, Hahm, Brandon, Tomimatsu, Nozomi, Bachoo, Robert M., Burma, Sandeep
Publicado em 2010

Reoxygenation of Hypoxic Glioblastoma Multiforme Cells Potentiates the Killing Effect of an Interleukin-13-Based Cytotoxin

Por Liu, Tie Fu, Cai, Jiaozhong, Gibo, Denise M., Debinski, Waldemar
Publicado em 2009

The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells

Por Salem, Israa, Alsalahi, Manal, Chervoneva, Inna, Aburto, Lucy D., Addya, Sankar, Ott, Gregory R., Ruggeri, Bruce A., Cristofanilli, Massimo, Fernandez, Sandra V.
Publicado no Breast Cancer Res (2016)

A pseudogene-signature in glioma predicts survival

Por Gao, Kai-Ming, Chen, Xin-cheng, Zhang, Jun-xia, Wang, Yingyi, Yan, Wei, You, Yong-Ping
Publicado no J Exp Clin Cancer Res (2015)

Cancer incidence and mortality in Shandong province, 2012

Por Fu, Zhentao, Lu, Zilong, Li, Yingmei, Zhang, Jiyu, Zhang, Gaohui, Chen, Xianxian, Chu, Jie, Ren, Jie, Liu, Haiyan, Guo, Xiaolei
Publicado no Chin J Cancer Res (2016)

CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo

Por Meng, Wei, Wang, Jiajia, Wang, Baocheng, Liu, Fang, Li, Meng, Zhao, Yang, Zhang, Chenran, Li, Qifeng, Chen, Juxiang, Zhang, Liye, Tang, Yujie, Ma, Jie
Publicado no Cancer Manag Res (2018)

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Por Wang, Jin, Liu, Xiaoyang, Hong, Yongzhi, Wang, Songtao, Chen, Pin, Gu, Aihua, Guo, Xiaoyuan, Zhao, Peng
Publicado no J Exp Clin Cancer Res (2017)

Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke

Por Ishrat, Tauheed, Pillai, Bindu, Ergul, Adviye, Hafez, Sherif, Fagan, Susan C
Publicado em 2013

Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2 amplified and TP53 wild-type glioblastomas

Por Verreault, Maite, Schmitt, Charlotte, Goldwirt, Lauriane, Pelton, Kristine, Haidar, Samer, Levasseur, Camille, Guehennec, Jeremy, Knoff, David, Labussiere, Marianne, Marie, Yannick, Ligon, Azra H., Mokhtari, Karima, Hoang-Xuan, Khe, Sanson, Marc, Alexander, Brian M, Wen, Patrick Y., Delattre, Jean-Yves, Ligon, Keith L., Idbaih, Ahmed
Publicado no Clin Cancer Res (2015)

Assessment Effects of Resveratrol on Human Telomerase Reverse Transcriptase Messenger Ribonucleic Acid Transcript in Human Glioblastoma

Por Mirzazadeh, Azin, Kheirollahi, Majid, Farashahi, Ehsan, Sadeghian-Nodoushan, Fatemeh, Sheikhha, Mohammad Hasan, Aflatoonian, Behrouz
Publicado no Adv Biomed Res (2017)

Administration of non-torsadogenic human Ether-à-go-go Related Gene inhibitors is associated with better survival for high hERG-expressing glioblastoma patients

Por Pointer, Kelli B., Clark, Paul A., Eliceiri, Kevin W., Salamat, M. Shahriar, Robertson, Gail A., Kuo, John S.
Publicado no Clin Cancer Res (2016)

ET-11 RESVERATROL REGULATES GLIOBLASTOMA AND GLIOBLASTOMA STEM-LIKE CELLS VIA ANTI-TUMORIGENIC AKT DEPHOSPHORYLATION AND p53 ACTIVATION

Por Clark, Paul, Bhattacharya, Saswati, van Ginkel, Paul, Darjatmoko, Soesiawati, Elmayam, Ardem, Polans, Arthur, Kuo, John
Publicado em 2014

Halofuginone inhibits the establishment and progression of melanoma bone metastases

Por Juárez, Patricia, Mohammad, Khalid S., Yin, Juan Juan, Fournier, Pierrick GJ., McKenna, Ryan C., Davis, Holly W., Peng, Xiang H., Niewolna, Maria, Javelaud, Delphine, Chirgwin, John M., Mauviel, Alain, Guise, Theresa A.
Publicado no Cancer Res (2012)

Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI

Por Anwar, Mekhail, Molinaro, Annette M., Morin, Olivier, Chang, Susan M., Haas-Kogan, Daphne A., Nelson, Sarah J., Lupo, Janine M.
Publicado no Radiat Res (2017)

Involvement of miR-Let7A in inflammatory response and cell survival/apoptosis regulated by resveratrol in THP-1 macrophage

Por Song, Juhyun, Jun, Mira, Ahn, Mok-Ryeon, Kim, Oh Yoen
Publicado no Nutr Res Pract (2016)

BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis

Por Patel, Kirtesh R., Chowdhary, Mudit, Switchenko, Jeffrey M., Kudchadkar, Ragini, Lawson, David H., Cassidy, Richard J., Prabhu, Roshan S., Khan, Mohammad K.
Publicado no Melanoma Res (2016)

Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol

Por Teppola, Heidi, Sarkanen, Jertta-Riina, Jalonen, Tuula O., Linne, Marja-Leena
Publicado no Neurochem Res (2015)

Ensartinib (X-396) in ALK-positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study

Por Horn, Leora, Infante, Jeffrey R., Reckamp, Karen L., Blumenschein, George R., Leal, Ticiana A., Waqar, Saiama N., Gitlitz, Barbara J., Sanborn, Rachel E., Whisenant, Jennifer G., Du, Liping, Neal, Joel W., Gockerman, Jon P., Dukart, Gary, Harrow, Kimberly, Liang, Chris, Gibbons, James J., Holzhausen, Allison, Lovly, Christine M., Wakelee, Heather A.
Publicado no Clin Cancer Res (2018)

HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HAND

Por Jin, Jingji, Lam, Lucy, Sadic, Edin, Fernandez, Frank, Tan, Jun, Giunta, Brian
Publicado em 2012

Differential Expression of 2’,3’-Cyclic-Nucleotide 3’-Phosphodiesterase and Neural Lineage Markers Correlate with Glioblastoma Xenograft Infiltration and Patient Survival

Por Zorniak, Michael, Clark, Paul A., Leeper, Heather E., Tipping, Matthew D., Francis, David M., Kozak, Kevin R., Salamat, M. Shahriar, Kuo, John S.
Publicado em 2012